Mitchell Chorost, MD
Surgical Oncology · Greenvale, NYNPI 1356397244
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $5,125 of the $7,010 with a category attached, or 73.1%. Cardinal Health 414 LLC accounts for 69.9% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $5,145 and has fallen 89.5% since, to $540 in 2025.
Across 48 payments — averaging $146.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cardinal Health 414 LLC$5K
- TELA Bio, Inc.$592
- Johnson & Johnson$339
- Cumberland Pharmaceuticals, Inc.$321
- Merck$186
- Guard Medical Inc.$143
- plus $529 from 7 others
What the payments were for
- Consulting fees$5,12573%
- Food & beverage$1,88527%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cardinal Health 414 LLC | 1 | $4,900 |
| TELA Bio, Inc. | 4 | $592 |
| Johnson & Johnson(3 entities) | 3 | $339 |
| Cumberland Pharmaceuticals, Inc. | 18 | $321 |
| Merck | 10 | $186 |
| Guard Medical Inc. | 1 | $143 |
| Boston Scientific | 1 | $138 |
| Activ Surgical, Inc. | 1 | $137 |
| Covidien LP | 1 | $114 |
| Chiesi USA, Inc. | 4 | $66 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Galvanize Therapeutics, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,010 in reported general payments places this provider in the 80th percentile of 173 surgical oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Greenvale
- Sheldon FeldmanNew York$97K
- Kepal PatelNew York$94K
- Helen CappuccinoBuffalo$70K
- Jose Alberty OllerStaten Island$63K
- Megan WinnerMineola$51K
- George PlitasNew York$39K
- James ParkNew York$28K
- Anna WeissRochester$27K
- Michael LoweNew York$20K
- James NitzkorskiPoughkeepsie$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.